To find an effective medication for mild to moderate cases in non-hospitalized patients, a clinical trial underway at UB is testing drugs, including monoclonal antibody medications, in people with mild to moderate cases of COVID-19.
Several UB graduate schools and programs continued their upward trajectory in the U.S. News & World Report ranking of America’s Best Graduate Schools. The publication released its 2022 rankings today.
Two papers by University at Buffalo researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to treat it.
UB researchers have found evidence of the so-called California variants, B.1.427 and B.1.429, in virus samples of Western New Yorkers who tested positive in January.
UB officials are optimistic about the university’s ability to safely deliver the majority of fall courses with an in-person component this fall, given the tremendous progress being made against COVID-19.